Lumipulse® G SARS-CoV-2 Ag

For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection. 

The assay utilises proven CLEIA (chemiluminescent enzyme immunoassay) technology with results that are available in up to 35 minutes.

Contact sales for information
CE marked
Lumipulse® G SARS-CoV-2 Ag Immunoreaction Cartridges

Product number 260340

3 x 14 Tests
Lumipulse® G SARS-CoV-2 Ag Calibrators

Product number 231869

4 x 4 Concentrations
Lumipulse SARS-CoV-2 Ag Sample Extraction Solution set for Nasopharynx swab

Product number 231883

20 Tests
Sample Extraction Solution

Product number 234921

4 x 40mL
Sample Extraction Solution set

Product number 234914

50 Tests
Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

  • Contact sales for information
  • Details
  • Conditions of sale
  • Documentation
  • Insights
  • FAQ
  • Product inquiry
  • Related products